The following documents are relevant to the Supply Situation. The documents below represent guidance to physicians and patients in light of the current tight supply of Myozyme. They have been distributed to all treating physicians worldwide except those in the European Union (EU). Separate guidance will be sent to European healthcare professionals in accordance with the requirements of the European Medicines Agency (EMEA); We would encourage everyone to read the global update and MSWG guidance for detailed information on the global management plan.
Myozyme Pompe Program Update – Global Version
Myozyme (2000L) Pompe Program Update – US Version
Guidance to the Pompe Community on the Management of Myozyme Supply
IPA Statement Regarding the Management of Myozyme Supply – Advice to Patient Groups
IPA Statement Regarding the Management of Myozyme Supply – Advice to Pompe Patients
Myozyme Supply Frequently Asked Questions – compiled by the IPA (updated 18 January 2009)